At present, some potentially predictive biomarkers have been found for CDK4/6 inhibitors, such as cyclin E1 (CCNE1) [10], thymidine kinase 1 (TK1) mRNA expression [11], and circulating tumour DNA (ctDNA) [12]. This evidence concerns the gene CDK4 and neoplasm.